Atara Biotherapeutics
ATRA
ATRA
48 hedge funds and large institutions have $24.1M invested in Atara Biotherapeutics in 2024 Q2 according to their latest regulatory filings, with 13 funds opening new positions, 11 increasing their positions, 21 reducing their positions, and 47 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more ownership
Funds ownership: →
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
58% less capital invested
Capital invested by funds: $57.9M → $24.1M (-$33.8M)
72% less first-time investments, than exits
New positions opened: 13 | Existing positions closed: 47
Holders
48
Holding in Top 10
–
Calls
$265K
Puts
$67K
Top Buyers
| 1 | +$1.19M | |
| 2 | +$873K | |
| 3 | +$869K | |
| 4 |
RG
Redmile Group
San Francisco,
California
|
+$695K |
| 5 |
Prudential Financial
Newark,
New Jersey
|
+$309K |
Top Sellers
| 1 | -$3.44M | |
| 2 | -$1.8M | |
| 3 | -$764K | |
| 4 |
State Street
Boston,
Massachusetts
|
-$722K |
| 5 |
JGC
J. Goldman & Co
New York
|
-$685K |